Skip to main content
news
A view of the exterior of NXP semiconductors computer chip fabrication plant in Nijmegen, Netherlands March 14, 2024. REUTERS/Piroschka van de Wouw

Singapore Big Four law firm Allen & Gledhill is advising Vanguard International Semiconductor Corporation (VIS) on its proposed $7.8 billion joint venture with NXP Semiconductors, which is being represented by A&O Shearman.

The joint venture aims to construct a new 300mm semiconductor wafer manufacturing facility in Singapore, producing 130nm to 40nm mixed-signal, power management, and analogue products, targeting automotive, industrial, consumer, and mobile markets.

This development comes as Singapore continues to strengthen its role in the global tech supply chain, particularly in low-end chip manufacturing crucial for electric vehicles, smartphones, and other devices.

The city-state currently accounts for over 10 percent of global chip production and about 20 percent of semiconductor equipment manufacturing, and is the largest production hub outside the United States for U.S.-based firms such as Applied Materials and Micron.

The A&G team advising VIS includes partners Richard Young, Zhao Jiawei, Yeo Boon Kiat, Elsa Chen, and Peh Aik Hin.

The A&O team is being led by partner Tess Fang, and includes senior associate Matthew Gee and counsel Jackson Allen. Partners Noah Brumfield and Nigel Parker are advising on antitrust and IP, respectively.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Cleary, A&O Shearman advise on Goodyear's $701 mln Dunlop sale

Cleary Gottlieb has advised tyremaker Goodyear Tire & Rubber Company on the $701 million sale of its Dunlop brand to Japan's Sumitomo Rubber Industries (SRI), which was represented by A&O Shearman.

Mori Hamada, Nagashima Ohno advise on $1.6 bln bid for Fujitsu General

Japanese law firms Mori Hamada & Matsumoto and Nagashima Ohno & Tsunematsu are playing key roles in Paloma Rheem Holdings' 257 billion yen ($1.6 billion) offer to acquire air conditioner manufacturer Fujitsu General.

CAM, Khaitan, Linklaters act on $355 mln Sai Life Sciences IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas has driven the $355 million initial public offering of TPG-backed Indian healthcare R&D firm Sai Life Sciences, with Khaitan & Co and Linklaters advising the bookrunning lead managers. CAM has also acted for selling promoter shareholders Sai Quest Syn.